Pharmaceuticals, Biotechnology and Life Sciences
IRVINE, Calif.–(BUSINESS WIRE)–Baylx, Inc. (Baylx), a clinical-stage biopharmaceutical company dedicated to developing novel stem cell therapeutics and products to address…
by: Lucy WyndhamYoga can Reduce the Severity of Rheumatoid Arthritis There are over 1.3 million Americans battling rheumatoid arthritis (RA)…
Company Will Host Conference Call at 5:00 p.m. (ET) on Monday, April 8, 2019 DUBLIN, Ohio–(BUSINESS WIRE)–Navidea Biopharmaceuticals, Inc. (NYSE…
Myriad Genetics’ study results on development of the adjusted Vectra, announced Wednesday, found it outperforming typical measures of disease activity in predicting new joint damage in rheumatoid arthritis patients.
JHL Biotech said Wednesday its Clinical Trial Application (CTA) for use of its first product in pipleine, JHL1101 in Phase 1 and Phase 3 clinical trials in Non-Hodgkin’s Lymphoma patients has been accepted by the China Food and Drug Administration (CFDA).